18 results
8-K
ODYY
Odyssey Health, Inc.
13 Dec 23
Regulation FD Disclosure
5:10pm
. (the “Company”) announced that it had received stockholder approval at its Special Meeting held on December 7, 2023, for the asset sale of its neurological drug
8-K
EX-99.1
ODYY
Odyssey Health, Inc.
13 Dec 23
Regulation FD Disclosure
5:10pm
concussion, announces that it has received stockholder approval for the sale of its neurological drug platform technology.
A Special Meeting … of Odyssey stockholders was held on December 7, 2023, at the law offices of Brinen &Associates. At the Special Meeting, the stockholders: (1) approved
8-K
ODYY
Odyssey Health, Inc.
7 Dec 23
Submission of Matters to a Vote of Security Holders
5:10pm
of Security Holders.
On December 7, 2023, Odyssey Health, Inc. formerly known as Odyssey Group International, Inc. (“Odyssey”) held its Special Meeting … of Stockholders. At the Special Meeting, the stockholders: (1) approved the asset purchase agreement of its neurological drug therapies and technologies
424B3
gndgx 6e0q250browrxb
9 Aug 22
Prospectus supplement
9:26am
DEF 14A
cfzcgro40u9erfa9zvk
6 Aug 21
Definitive proxy
4:02pm
PRER14A
tqf293
28 May 21
Preliminary revised proxy
5:09pm
S-3
4b9g70cum 4eaufs3uv1
17 Mar 21
Shelf registration
4:30pm
424B3
bf01wda3
8 Dec 20
Prospectus supplement
3:15pm
- Prev
- 1
- Next